Search research articles
Contact Us
Filters
Showing results (71-80 of 94) with videos related to
Page
of 10
Sort By:
Journal of the National Cancer Institute
|
February 2, 2021
The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32
Isabel Pimentel, Bingshu E Chen, Ana Elisa Lohmann, et al.
Clinical Chemistry
|
July 15, 2021
Clinical Translation and Evaluation of a Handheld and Biocompatible Mass Spectrometry Probe for Surgical Use
Jialing Zhang, Marta Sans, Rachel J DeHoog, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2016
Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast Cancer
Peter Schmid, Sarah E Pinder, Duncan Wheatley, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 14, 2010
DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability
Fanny Lemée, Valérie Bergoglio, Anne Fernandez-Vidal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 18, 2020
Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists
Alice Y Ho, Jean L Wright, Rachel C Blitzblau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2018
Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial
Simona F Shaitelman, Xiudong Lei, Alastair Thompson, et al.
BMJ (Clinical Research Ed.)
|
October 30, 2023
Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study
Renée S J M Schmitz, Alexandra W van den Belt-Dusebout, Karen Clements, et al.
JAMA Oncology
|
December 12, 2024
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical Trial
Ann H Partridge, Terry Hyslop, Shoshana M Rosenberg, et al.
Lancet (London, England)
|
November 15, 2013
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial
Jayant S Vaidya, Frederik Wenz, Max Bulsara, et al.
JCO Precision Oncology
|
December 18, 2025
Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer
Beatriz E Adrada, Mary S Guirguis, Lei Huo, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 94) with videos related to
Sort By:
Page
of 10
Journal of the National Cancer Institute
|
February 2, 2021
The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32
Isabel Pimentel, Bingshu E Chen, Ana Elisa Lohmann, et al.
Clinical Chemistry
|
July 15, 2021
Clinical Translation and Evaluation of a Handheld and Biocompatible Mass Spectrometry Probe for Surgical Use
Jialing Zhang, Marta Sans, Rachel J DeHoog, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2016
Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast Cancer
Peter Schmid, Sarah E Pinder, Duncan Wheatley, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 14, 2010
DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability
Fanny Lemée, Valérie Bergoglio, Anne Fernandez-Vidal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 18, 2020
Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists
Alice Y Ho, Jean L Wright, Rachel C Blitzblau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2018
Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial
Simona F Shaitelman, Xiudong Lei, Alastair Thompson, et al.
BMJ (Clinical Research Ed.)
|
October 30, 2023
Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study
Renée S J M Schmitz, Alexandra W van den Belt-Dusebout, Karen Clements, et al.
JAMA Oncology
|
December 12, 2024
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical Trial
Ann H Partridge, Terry Hyslop, Shoshana M Rosenberg, et al.
Lancet (London, England)
|
November 15, 2013
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial
Jayant S Vaidya, Frederik Wenz, Max Bulsara, et al.
JCO Precision Oncology
|
December 18, 2025
Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer
Beatriz E Adrada, Mary S Guirguis, Lei Huo, et al.
Page
of 10